# Virocell Biologics Ltd (13033264)

> Why UK company 13033264 went into administration, from the administrators' statement filed at Companies House, by companydig. Interactive version: https://companydig.co.uk/company/13033264

- **Status:** In administration
- **Administration began:** 2025-11-28
- **Administrators:** Chad Griffin, Simon Baggs
- **Administrators' firm:** FRP Advisory
- **Incorporated:** 2020-11-20
- **Location:** London
- **Industry:** 72110 Research and experimental development on biotechnology

## Why it went into administration

- Cash flow / liquidity pressure
- Rising costs / inflation
- Funding withdrawn / unable to refinance

## From the administrators' statement

At the end of 2024 and the beginning of 2025, the Company began suffering significant financial difficulties due to factors out of its control, such as, tariffs imposed on global trade, inflation and funding cuts. These external financial pressures in tandem with high overheads associated with the industry resulted in the Company suffering severe cashflow pressure.

Throughout 2025, the Company sought to gain essential cash injection by way of achieving a merger with a large player in the medical-technology industry. This was to be achieved by bridging its funding gap through its investor base, by virtue of Convertible Loan Notes.

Virocell Biologics Ltd (in Administration) The Administrators’ Proposals

Statement of proposals: https://find-and-update.company-information.service.gov.uk/company/13033264/filing-history/MzQ5MjU5MTc0N2FkaXF6a2N4/document?format=pdf&download=0
Companies House register: https://find-and-update.company-information.service.gov.uk/company/13033264

Contains public sector information from Companies House, licensed under the Open Government Licence v3.0.